地塞米松作为儿童及青少年膝关节镜术中股神经阻滞佐剂:前瞻性随机双盲安慰剂对照试验
该研究纳入10-18岁行膝关节镜手术并接受股神经阻滞的儿童及青少年,随机分为罗哌卡因加神经周围地塞米松、罗哌卡因加肌内地塞米松和罗哌卡因加安慰剂三组。主要结局为出院后48小时内镇痛药使用次数,三组间无显著差异,神经周围或肌内地塞米松均未改善镇痛效果。
要点
- 儿童膝关节镜股神经阻滞中,神经周围或肌内地塞米松未减少出院后48小时镇痛药使用次数。
- 地塞米松两种给药途径在主要结局上无显著差异,其他次要结局亦无统计学差异。
- 结果是否反映成人-儿童真实差异或研究局限性尚不能确定,需进一步儿童研究。
核心结论
- 在儿童及青少年中,神经周围或肌内地塞米松均未改善膝关节镜股神经阻滞后的镇痛效果。
研究设计与样本
- 前瞻性、随机、双盲、安慰剂对照试验,纳入10-18岁行膝关节镜手术并接受股神经阻滞的儿童及青少年。
主要发现
- 出院后48小时内镇痛药使用次数中位数:神经周围地塞米松组2次、肌内地塞米松组3次、对照组2次。
- 神经周围地塞米松组与肌内地塞米松组比较:中位数差1,95%CI -1至2,P=0.475。
- 神经周围地塞米松组与对照组比较:中位数差0,95%CI -2至1,P=0.821。
- 肌内地塞米松组与对照组比较:中位数差-1,95%CI -2至1,P=0.594。
- 出院后首次镇痛药使用时间、视觉模拟量表疼痛评分和主观运动阻滞强度等次要结局组间均无统计学显著差异。
临床怎么用
- 对于10-18岁行膝关节镜手术的儿童及青少年,股神经阻滞时不应常规添加神经周围或肌内地塞米松以延长术后镇痛。
局限性
- 研究无法确定观察到的缺乏获益反映的是成人-儿童真实差异还是研究局限性。
- 未来需要儿童研究评估地塞米松用于其他阻滞类型和其他手术类型的效果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Perineural dexamethasone has been demonstrated to extend postsurgical analgesia after peripheral nerve blockade in adults. The mechanism of action of dexamethasone as a regional anesthetic adjuvant is unclear as intravenous dexamethasone has been shown to have similar analgesic efficacy as perineural dexamethasone. The efficacy of perineural dexamethasone has not been previously explored in the pediatric population. METHODS: After obtaining informed consent, children (aged 10-18 years) presenting for arthroscopic knee surgery with a femoral nerve block were randomized to 1 of 3 groups: ropivacaine 0.5% and intramuscular saline (group R), ropivacaine 0.5% plus perineural dexamethasone 0.1 mg/kg (maximum 4 mg) and intramuscular saline (group D), and ropivacaine 0.5% and intramuscular dexamethasone 0.1 mg/kg (maximum 4 mg) (group M). The primary outcome was the number of doses of analgesic agents in the first 48 hours after hospital discharge. The number of doses was compared across study groups using Wilcoxon rank sum tests. RESULTS: Seventy-seven patients were enrolled in the study, of whom 4 were withdrawn because of additional surgical repair being performed, emergence delirium requiring unblinding, or loss to follow-up. The remaining 36 boys and 37 girls (aged 15 ± 2 years) included 23 patients randomized to group D, 23 patients randomized to group M, and 27 patients randomized to group R. The median number of pain medication doses within 48 hours of discharge was 2, 3, and 2 in groups D, M, and R, respectively. There were no significant differences in this outcome between groups D and M (difference in medians, 1; 95% confidence interval [CI] of difference in medians, -1 to 2; P = 0.475), groups D and R (difference in medians, 0; 95% CI of difference, -2 to 1; P = 0.821), or groups M and R (difference in medians, -1; 95% CI of difference, -2 to 1; P = 0.594). Other secondary outcomes, including time to first analgesic consumption after discharge, visual analog scale pain score, and subjective intensity of motor block, did not evince statistically significant differences among the study groups. CONCLUSIONS: In the pediatric population, perineural or intramuscular dexamethasone did not improve analgesia after femoral nerve blockade for knee arthroscopy. Whether the observed lack of benefit reflects a true adult-pediatric difference or a limitation of the study could not be determined. Future pediatric studies are needed to evaluate dexamethasone for other block types and other types of surgery. CLINICAL TRIAL REGISTRATION: This study was registered at ClinicalTrials.gov, identifier NCT01971645.
引用
- Veneziano G, Martin DP, Beltran R, et al. Dexamethasone as an Adjuvant to Femoral Nerve Block in Children and Adolescents Undergoing Knee Arthroscopy: A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial. Reg Anesth Pain Med. 2018. PMID: 29377866. doi:10.1097/AAP.0000000000000739
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。